Following MTE treatment, the PD-1 expression in tumor-infiltrating lymphocytes (TILs) was unchanged, but PD-L1decreased in the tumor cells in 9 patients, suggesting a decrease in the immune escape of cancer cells by PD-L1 inhibition. This evidence concerns the gene CD274 and neoplasm.